Paladin receives sub-license from BioSante

BioSante (BTPH; CDNX:BAI) granted Paladin (TSE:PLB) an exclusive sub-license to its female hormone replacement therapies for marketing in Canada. BTPH will receive an initial investment and is eligibl...